Nanostructured particles assembled from natural building blocks for advanced therapies

Y Ju, H Liao, JJ Richardson, J Guo… - Chemical Society …, 2022 - pubs.rsc.org
Advanced treatments based on immune system manipulation, gene transcription and
regulation, specific organ and cell targeting, and/or photon energy conversion have …

Secreted protein acidic and rich in cysteine mediated biomimetic delivery of methotrexate by albumin-based nanomedicines for rheumatoid arthritis therapy

L Liu, F Hu, H Wang, X Wu, AS Eltahan, S Stanford… - ACS …, 2019 - ACS Publications
Rheumatoid arthritis (RA) is one of the most common chronic autoimmune diseases. Despite
considerable advances in clinical treatment of RA, suboptimal response to therapy and …

Stromal protein-mediated immune regulation in digestive cancers

P Gamradt, C De La Fouchardière, A Hennino - Cancers, 2021 - mdpi.com
Simple Summary Solid cancers are surrounded by a network of non-cancerous cells
comprising different cell types, including fibroblasts, and acellular protein structures. This …

SPARC-p53: The double agents of cancer

D Camacho, JP Jesus, AM Palma, SA Martins… - Advances in cancer …, 2020 - Elsevier
Cancer is a complex disease with high incidence and mortality rates. The important role
played by the tumor microenvironment in regulating oncogenesis, tumor growth, and …

USP22 Suppresses SPARC Expression in Acute Colitis and Inflammation-Associated Colorectal Cancer

RL Kosinsky, D Saul, C Ammer-Herrmenau… - Cancers, 2021 - mdpi.com
Simple Summary Intestinal inflammation leads to an increased risk of developing colorectal
cancer (CRC) and incidences are expected to rise. Therefore, it is crucial to identify …

SPARC: a potential target for functional nanomaterials and drugs

S Jiang, HF Sun, S Li, N Zhang, JS Chen… - Frontiers in Molecular …, 2023 - frontiersin.org
Secreted protein acidic and rich in cysteine (SPARC), also termed osteonectin or BM-40, is a
matricellular protein which regulates cell adhesion, extracellular matrix production, growth …

A four gene-based risk score system associated with chemoradiotherapy response and tumor recurrence in rectal cancer by co-expression network analysis

Y Sun, Y Zhang, X Wu, P Chi - OncoTargets and therapy, 2020 - Taylor & Francis
Aim Resistance to neoadjuvant chemoradiotherapy (NCRT) and tumor recurrence presents
a major clinical problem in locally advanced rectal cancer (LARC) patients. This study aimed …

[HTML][HTML] Nab-paclitaxel as first line treatment for NSCLC in elderly patients more than 75 years old

P Zarogoulidis, H Huang, C Bai, D Petridis… - Journal of …, 2017 - ncbi.nlm.nih.gov
Introduction: Lung cancer is still the leading cause of cancer among cancer patients.
Although there are novel therapies as second line treatment for NSCLC, there is an issue for …

Pan-cancer analyses reveal prognostic value of osteomimicry across 20 solid cancer types

C Yang, H Pan, L Shen - Frontiers in Molecular Biosciences, 2020 - frontiersin.org
Background Osteomimicry of cancer cells had been widely reported in prostate cancer and
breast cancer. However, the prognostic value of osteomimicry in various cancer types …

[PDF][PDF] Prognostic Molecular Markers of Response to Radiotherapy in Rectal Cancer

WS Taylor - Thesis, 2021 - ourarchive.otago.ac.nz
Colorectal cancer (CRC) is the second most deadly cancer globally, and 30% of these
cancers occur in the rectum. The primary treatment for CRC is surgery, often radiotherapy …